CytoSorbents (CTSO) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

CytoSorbents Corp (CTSO) Prix de l'Action, Cotation, Actualités et Historique

CTSONASDAQ

Trade with Public

Trade with Public

$4.96

0.8520.68%

Dern. MÀJ: Oct 19, 4:29 PM

$4.80

0.6916.79%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

$4.13

Clôture

$4.96

Volume / Moy.

255.89K / 12.71K

Fourchette Journalière

$4.13 - $5.33

Plage 52 Sem.

2.84 - 18.80

Capitalisation Boursière

$15.13M

Ratio P/E

-

Rendement des Dividendes

-

Échange

NASDAQ

RSI

36

Intérêt à Découvert

4.27%

Jours pour Couvrir

11.98

Actualités Récentes de Cytosorbents Corp

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth

CytoSorbents is progressing with U.S. FDA and Health Canada reviews for its DrugSorb-ATR device.

Lekha Gupta

Why CytoSorbents (CTSO) Stock Is Trading Higher

CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group.

Henry Khederian

Gold Moves Lower; US Crude Stocks Decline Last Week

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90. The S&P 500 also rose, gaining, 0.23% to 4,792.56.

Avi Kapoor

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Avi Kapoor

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

-9.15M

Flux de Trésorerie d'Investissement (TTM)

-275.00K

Flux de Trésorerie de Financement (TTM)

2.48M

Flux de Trésorerie Libre (TTM)

-9.58M

Dépenses en Capital (TTM)

-436.00K

Variation Nette de la Trésorerie (TTM)

-6.94M

Évaluation et prévisions des analystes

3.8

Acheter

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$37.68M

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

0.34

Ratio P/B (TTM)

-

Rendement des Bénéfices % (TTM)

-144.31%

Rendement des Bénéfices % (FWD)

-22.39%

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

-

Valeur Comptable / Action

-$0.24

Dette Entreprise

Dette Totale

$17.24M

Dette à Long Terme

$3.09M

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-

Trésorerie Totale

$4.41M

Dette sur Capitaux Propres

-

Émission de Dette (TTM)

-

Remboursement de la Dette (TTM)

-